
An Immunotherapeutic Shows Promise for Multiple Myeloma Patients Ineligible for Pivotal Trial
Study found teclistamab-cqyv, an immunotherapy, led to responses in patients with high-risk, heavily pretreated multiple myeloma, including after prior...
Study found teclistamab-cqyv, an immunotherapy, led to responses in patients with high-risk, heavily pretreated multiple myeloma, including after prior...
Incidence-based mortality is also projected to increase with disproportionately higher rates for Black women compared with white women. Incidence...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
The largest increases were found in breast, colorectal, endometrial, pancreatic, and kidney cancers. Early-onset cancers, or cancers diagnosed in...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he...
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
Natalie Snider-Hoy, a PhD candidate at Wayne State University, attended AACR Early-career Hill Day 2025 to advocate for sustained...
Radiation plus immunotherapy may help some patients with invasive bladder cancer keep their bladders. Patients with localized muscle-invasive bladder...
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.